Objective Tracking the migration of superparamagnetic iron oxide (SPIO)-labeled immune cells in vivo is valuable for understanding the immunogenic response to cancer and therapies. Quantitative cell tracking using TurboSPI-based R 2 * mapping is a promising development to improve accuracy in longitudinal studies on immune recruitment. However, offresonance fat signal isochromats lead to modulations in the signal time-course that can be erroneously fit as R 2 * signal decay, overestimating the density of labeled cells, while excluding voxels with fat-typical modulations results in underestimation of cell density in voxels with mixed content. Approaches capable of accurate R 2 * estimation in the presence of fat are needed. Methods We propose a dual-decay (separate R 2f * and R 2w * for fat and water) Dixon-based signal model that accounts for the presence of fat in a voxel to provide better estimates of SPIO-induced dephasing. This model was tested in silico, in phantoms with varying quantities of fat and SPIO-labeled cells, and in 5 mice injected with SPIO-labeled CD8+ T cells. Results In silico single voxel simulations illustrate how the proposed dual-decay model provides stable R 2w * estimates that are invariant to fat content. The proposed model outperforms previous methods when applied to in vitro samples of SPIOlabeled cells and oil prepared with oil content ≥ 15%. Preliminary in vivo results show that, compared to previous methods, the dual-decay model improves the balance of R 2 * mapping in fat-dense areas, which will yield more reliable analysis in future cell tracking studies. Discussion The proposed model is a promising tool for quantitative TurboSPI R 2 * cell tracking, with further refinements offering the possibility of better specificity and sensitivity.
Introduction
Immunotherapies are a rapidly growing field of cancer treatments that have had varying degrees of success in the clinic [1, 2] . Using imaging to track the migration of immune cells in response to both cancer and cancer therapies is valuable for understanding the underlying immunogenic mechanisms, particularly when used longitudinally. Analyzing immune cell recruitment is especially important when studying immunotherapies, which do not always fit traditional metrics of therapy success [3, 4] ; alternative metrics based on immune activity may be more relevant.
MRI is one of the most promising modalities for immune cell tracking due to its high resolution, lack of invasiveness and good sensitivity with choice of appropriate contrast agent. Superparamagnetic iron oxide nanoparticles (SPIO) are the most popular MRI contrast agent for cell tracking [5] [6] [7] [8] [9] . SPIO-labeled cells are often imaged using a balanced steady-state free precession (bSSFP) sequence [5] [6] [7] [8] [9] , which is ideal for its high SNR and sensitivity to SPIO effects [10] .
Unfortunately, there are well-documented challenges associated with tracking SPIO-labeled cells [11] . For example, specificity issues arise when endogenous sources of negative contrast, such as tumor necrosis (as seen in [12] ), are misinterpreted as the hypo-intense signal voids associated with clusters of labeled cells. Accounting for false positives requires integration with biological techniques via tumor necropsy and histochemistry to validate findings for each subject, which is difficult to scale to large studies and eliminates the possibility of longitudinal studies.
Quantification is another challenge for MRI cell -tracking applications, since sequences like bSSFP enable only qualitative analysis of changes in image contrast. The analysis can become semi-quantitative by comparing the signal intensity histograms before and after labeled cell injection [12] or using a matched control [7] , but these methods offer only relative quantification. Relaxation rate mapping is a popular method for attempting to quantify SPIO-labeled cells, since R 2 * (R 2 * = 1/T 2 *) increases linearly as a function of cell density [13, 14] . However, many R 2 * mapping techniques proposed to date are unable to resolve rapidly decaying signals, which restricts quantitative dynamic range; these methods are also prone to 'blooming' artifacts induced by the very species which they are intended to quantify [15, 16] .
Fluorine-19 ( 19 F)-based methods address some of these issues [17] [18] [19] , but these gains are countered by a significant decrease in sensitivity compared to proton MRI [18] , thereby requiring far more injected cells, larger numbers of cells being recruited to regions of interest, or a higher concentration of 19 F to be localized within cells. Previous work done by our laboratory demonstrated the use of 3D TurboSPI for quantifying labeled cells [15, 16] . TurboSPI is a multi-echo single point imaging (SPI) sequence that was first developed for porous media with short T 2 * relaxation times (~ 1 ms). Rather than a single data point following an excitation, our implementation collects several hundred points, in a manner similar to spectroscopic imaging but at much higher temporal resolution (typical sample rates of ~ 100 kHz). This enables high fidelity R 2 * mapping with greater dynamic range and fewer artifacts due to the purely phase-encoded acquisition [15, 16, 20, 21] . It is important to note that even R 2 * mapping will not be able to quantify single cells, or very small numbers of cells, since assumptions are being made about average iron uptake and distribution within a voxel. Similar assumptions are necessary with 19 F imaging involving average 19 F uptake within cells. However, improved R 2 * quantification is still extremely useful for comparing cell recruitment across multiple time points and between different groups, enabling important biological questions to be explored.
The TurboSPI sequence is designed for imaging species with R 2 * >> R 2 and the resulting time series data is sensitive to the compartmentalized SPIO encapsulated in cells rather than free iron. The signal decay from SPIO-labeled cells can therefore be distinguished from that of free iron in blood (i.e., in necrotic regions) or loose SPIO. This removes a common source of false positives associated with bSSFP sequences. Purely phase-encoded sequences like TurboSPI are also well suited to acceleration with compressed sensing, and with sufficient acceleration it is feasible to use TurboSPI for in vivo studies [16] .
While initial TurboSPI studies have proven promising, a pilot preclinical in vivo study that compared multiple immunotherapy treatment groups [22] revealed a new potential source of error: the presence of off-resonance fat modulations in the signal time course. Since the original analysis used a simple mono-exponential model to estimate the R 2 * relaxation parameter, fat signal modulations can falsely indicate elevated signal decay, resulting in apparent regions of elevated R 2 * decay falsely appearing as elevated SPIO-labeled cell density. That is, one specificity issue was traded for another in the form of false positives from fat. These errors are especially problematic near the fat pads at the tumor periphery and lymph nodes, areas of potentially high cell recruitment (shown in [22] ). The larger voxels necessitated by SPI can result in mixed content of fat and SPIO-labeled cells, such that the associated time course will reflect both types of signal evolution. Masking out voxels whose time course contains modulations at the typical lipid frequency (447 Hz) will eliminate fat-contaminated voxels from the map, but this leads to underestimates in cell numbers.
More robust analysis to accommodate voxels containing both labeled cells and fat is required. In this work, we propose a modified Dixon-based signal model that simultaneously estimates R 2 * and fat fraction to improve fitting accuracy, such that R 2 * can be quantified independent of the fat content within a voxel. The converse problem has been investigated previously in the literature; for example, Yu [23] , O'Regan [24] , Chebrolu [25] and Reeder [26] obtained accurate information of fat content in the liver, regardless of R 2 * effects from hepatic iron. However, this is the first attempt to address the problem of improving the accuracy of R 2 * estimates in TurboSPI in the presence of fat.
This work begins with an in silico investigation to characterize the problem, an in vitro experiment to validate the improved fitting scheme on real data, and finally a preclinical in vivo test on mice injected with SPIO-labeled cells.
Experimental

Models used
Three fitting models/techniques were compared in these experiments. The simplest method is a mono-exponential single species (water) decay model (Eq. 1), or "singledecay" technique. This method simply fits the magnitude portion of the signal decay as where W is the signal amplitude for the water isochromat and T 2 * is the decay rate of water. Δt is the difference in time between the center of the spin echo peak and the data acquisition.
The second technique attempts to address fat voxels by performing a post-acquisition fat exclusion combined with the single-decay model, henceforth referred to as the "exclusion" technique. During the fitting process, the algorithm identifies modulations in the time course that have fat-specific periodicity, and excludes these voxels from the analysis, i.e., sets R 2 * = 0 s −1 for each of those voxels. For the exclusion criteria, fat is identified when there are significant discontinuities in signal phase around TE ± 1.1 ms, i.e., when the fat and water signals are out of phase. This technique was previously applied to in vivo data, but is unable to address "mixed voxels" containing both fat and SPIO-labeled cells [22] .
The third technique is the proposed model: modified dualdecay Dixon, or the "dual-decay" technique, which simultaneously estimates the fat fraction as well as separate R 2 * relaxation rates for fat and water (Eq. 2).
where W and F are signal amplitudes for the water and fat isochromats, respectively, T 2w * and T 2f * are separate decay rates for the water and fat species, Δω wf is the frequency offset between the isochromats, ϕ o is a time-independent phase offset, and θ τ is a slow time-dependent phase change due to the SPIO [27] . A time-dependent inhomogeneity term (ϕ) is not given explicitly; however, for in vitro and in vivo studies, the terms of θ τ and Δω wf are allowed to reflect the effects of unintended inhomogeneity.
Dual-T 2 * Dixon models have been used in the literature for other purposes. Chebrolu [25] and O'Regan [24] investigated the improvement of fat quantification using independent T 2 * estimates, and Horng [28] and Reeder [26] compared methods that use T 2 * to correct fat quantification. Replacing a common T 2 * with independent fat and water T 2 * values has been debated in the literature. Chebrolu found that using dual T 2 * correction methods reduces error, especially
in phantoms with high levels of both SPIO and fat [25] , since the SPIO has a greater T 2 * effect on water than fat.
In silico investigation and model development
In silico analyses were performed to investigate the combined effects of R 2 * decay and fat modulations. All aspects of the in silico work were implemented using customized in-house Matlab 2017b code (Mathworks, Natick, MA). The TurboSPI signal was first simulated without fat contributions using Monte Carlo methods, which are described in more detail elsewhere [27, 29, 30] . Briefly, water molecules diffuse through a randomly distributed grid of spherical magnetic field perturbers of defined size, susceptibility and volume fraction. The magnetic field experienced by each proton is calculated at each time step to track the accumulated phase. The echo time (TE), repetition time (TR), and sampling rate were matched to the TurboSPI sequence used for in vitro and in vivo experiments. The result is a complex magnetization time course computed from the excitation pulse through the spin echo to t = 3TE/2. N = 30,000 independent simulations were summed to give the final signal, an example of which is shown in Fig. 1 with the typical acquisition window (for in vitro/in vivo data) highlighted. T 2 relaxation was simulated to be long (1 s), a reasonable simplification since T 2 >> T 2 * for SPIO compartmentalized in cells [31] .
In this work, a simplified single-peak lipid model with the common chemical shift of 3.5 ppm (Δf wf = 447 Hz at 3 T) is added to the simulations. The signal from fat (S f = e^{− i2π(γBo − Δf wf )t} was added to the simulated TurboSPI signal for various fat fractions (ff = 0-100% in steps of 1%) to represent lipid contributions (Fig. 1 ). Rather than estimating fat fraction separately to correct the R 2 * measurement, both parameters are estimated simultaneously using the dual-decay model (Eq. 2).
Presently, the fit is only performed on the portion of the decay from t = 10.5 ms to t = 12.5 ms. This is to avoid the spin echo peak at TE = 10 ms, near which there exists a deviation from the model's predicted exponential decay (the presence of diffusion gives rise to non-exponential signal attenuation [32] ). Away from t = TE, this additional factor approaches unity and the proposed model becomes valid.
The real and imaginary channels were concatenated and fit as a single unit to accommodate bounded optimization using Matlab's lsqcurvefit, which does not support bounds for complex inputs. Data were simulated and fit with a range of fat fractions from 0 to 1, to demonstrate stability in the T 2* measurement, and with a range of perturber volume fractions to ensure stability with respect to cell density. Estimated fat fractions were compared to the known input, and estimated T 2w * values were compared to the gold standard value obtained from fitting a mono-exponential decay with no added fat.
In vitro experiment
Images were acquired using phantoms prepared with equal concentrations of SPIO-labeled cells, but varying fat fractions and two "no cell" controls. Cells were isolated from C57BL/6 mice obtained from Charles River Laboratories (St. Constant, PQ); all procedures adhered to approved ethics protocols for animal care according to the University Committee on Laboratory Animals, Dalhousie University. CTLs were harvested from the inguinal, mesenteric, brachial, axillary, and submandibular lymph nodes from C57BL/6 mice, cultured according to internal protocols over 8 days, and loaded with Rhodamine B SPIO nanoparticles (30 nm, Biopal, Worcester MA) to a concentration of 5 pg/cell using passive in vitro incubation for 24 h.
Solutions of SPIO-labeled cells, water, and peanut oil were suspended in a polyacrylamide gel and placed in 5 mm NMR tubes. The gel contained 10% sodium dodecyl sulfate, 40% acrylamide, 1 M hydroxyethyl piperazineethanesulfonic acid (HEPES), 10% ammonium persulfate, and tetramethylethylenediamine. Nine such phantoms were created: seven with SPIO-labeled cells (fat content = 0, 5, 10, 15, 20, 30, 40%) and two controls with no cells (20, 40% fat). The phantoms with SPIO-labeled cells contained a constant concentration of 2 × 10 6 SPIO-loaded CD8 + T lymphocytes (CTLs) per 1 mL solution.
All MR data were acquired using a 3 T horizontal bore pre-clinical MR scanner (Oxford, UK, console by Agilent, Santa Clara, CA). For imaging, NMR tubes were placed inside a cylindrical MR-transparent phantom holder filled with doped water (160 × 10 -6 M MnCl 2 ). Samples were imaged in sets of three using a 2D TurboSPI sequence [16] (TR = 250 ms, TE effective = 10 ms, ETL = 8, ESP = 10 ms, matrix = 128 × 128, FOV = 50 × 50 mm 2 , scan time 8.5 min) with and without a chemically selective fat saturation pulse (90° sinc). Signal time course data were fit for each voxel using the exclusion method [22] and dual-decay model (Eq. 2). When fitting in vitro data, the time-dependent variables θ τ and Δω wf also incorporate the effects of Bo inhomogeneity, without the need for a separate fitting parameter. While fat fraction, T 2w * and T 2f *, are considered in the fit, it is R 2w * = 1/T 2w * that is the parameter of interest which is output explicitly and reported in the final relaxation maps.
In vivo experiment
On day 0, C57BL/6 mice (n = 5) received a subcutaneous injection of C3 cells from the murine cervical cancer C3 cell line [7, 33, 34] (5 × 10 5 cells in 100 μL in the left flank). CTLs were again harvested from the inguinal, mesenteric, brachial, axillary, and submandibular lymph nodes of disease-matched donor mice (implanted day-7), isolated and cultured according to internal protocols (day 12-day 19). CTLs were primed, using antigen presenting cells (APCs) at a ratio of 1:10 APCs:CTLs, to recognize the R9F antigen of C3 cells [7] , thereby promoting cellular recruitment. The CTLs were loaded with SPIO nanoparticles on day 19 (30 nm, Biopal, Worcester MA) and 8 × 10
6 SPIO-labeled CTLs were delivered via tail vein injection on day 20. The animal subjects were imaged 24 h after injection to allow for biological uptake.
A high-resolution anatomical scan was performed first using bSSFP (TR = 8 29 min). A matched parameter fast spin echo (FSE) pre-scan (scan time 2.5 min) preceded the 3D TurboSPI sequence to guide the pseudo randomly undersampled acquisition and constrain the final compressed sensing (CS) reconstruction. The PET parameters are described in supplemental methods. After the CS reconstruction was performed using an inhouse Matlab program [15] , the time course data were fit for each voxel using three techniques: single-decay (Eq. 1), exclusion (as in in vitro) study, and dual decay (Eq. 2). 3D bSSFP and R 2 * data were co-registered rigidly using the FSE scan as an intermediary and fused in VivoQuant (invi-CRO, Boston MA) for visualization. All in vivo images were masked using a hand-drawn region encompassing the tumor and surrounding fat pads including the tumor-draining inguinal lymph node. Figure 2 demonstrates issues with non-specific SPIO contrast obtained using bSSFP. The red circle demonstrates an area of hypointensity in a C3 tumor in mice having received an injection of SPIO-labeled CD8 + T cells. While this hypointensity could be assumed to be cells, the overlay of 18 F-FDG activity demonstrates that this area is not metabolically active compared to the rest of the tumor indicating it is likely necrotic tissue and would be a "false positive". Figure 4 gives an example of the fitted time course for one set of parameters. Though the split real-imaginary function (Fig. 4b) is less visually intuitive as a signal time course than the complex equivalent (Fig. 4a) , this allows a bounded fit that provides better performance for noisy data while still matching well with the simulation (RMSE = 9.4 × 10 -4 ), The accuracy of fat estimation over a range of simulated fat fractions is shown in Fig. 5a , while Fig. 5b shows the stability of the water T 2 * parameter estimate across the range of fat fractions for three different perturber volume fractions. When fit properly, the water and fat terms are separated appropriately, and T 2w * is invariant to fat content while changing appropriately at different volume fractions (i.e., different cell densities). This stable behavior is observed from 0-99% fat (with a slight deviation at fat = 0-5%), suggesting that the dual-decay model is stable for mixed voxels, but the fit deteriorates at 100% fat since the model is no longer appropriate. The unstable behavior before 5% produces a small deviation that is only visible for idealized simulated data and is within the expected uncertainty of physical measurement. Standard deviations (σ) of the T 2w* measurements from 0-99% fat are σ = 0.23 ms (ζ = 1.0 × 10 -5 ), 0.16 ms (ζ = 1.5 × 10 -5 ), and 0.12 ms (ζ = 2.0 × 10 -5 ), reflecting how fit performance improves with increased SPIO effect.
Results
Current limitations with in vivo SPIO imaging
In silico
White Gaussian noise was added to simulate TurboSPI data to investigate noise performance of the proposed dual-decay model. This model was evaluated for 20 different repetitions each at five fat fractions, with temporal 18 F-FDG PET/MRI overlay using simultaneously obtained PET data. A necrotic core is confirmed by low 18 F-FDG activity aligned with the hypointense region on the MRI signal-to-noise ratios (tSNR) of 1-40. The mean and standard deviation of the resulting fat fraction and T 2 * estimates are reported in Fig. 6 . While the dual-decay model exhibits poor predictive performance for very low tSNR, the mean estimates plateau at tSNR ~ 20. An in vivo TurboSPI scan typically has tSNR > 40. Fig. 4 a Normalized simulated complex data (magnitude shown, solid black) with the corresponding fit (dashed blue). The simulation is shown for t = 10 ms to 12.5 ms, but the fit is performed for t = 10.5 ms to 12.5 ms to avoid the spin echo peak. Simulation parameters: fat fraction ff = 0.15, ζ = 1.5 × 10-5, R = 8 µm, Δχ = 0.05, no T 2 * effect simulated for the fat species. T 2* estimate from fit = 4.38 ms, gold standard for same parameters but ff = 0 was T 2 * = 4.5 ms, b The same simulated data with concatenated real (black) and imaginary (blue) components and corresponding model fit (dashed grey). Same parameters as in (a) but with a simulated T 2* = 15 ms for the fat species. Water T 2* estimate from fit = 4.31 ms
In vitro
R 2w * maps calculated using the dual-decay model were compared to those calculated using the exclusion method (mono-exponential decay while eliminating voxels with fat periodicity). Ideally, the "no cell" (NC) tubes should have low R 2w *, the mixed fat/water tubes should have equal R 2w * to reflect their equal cell densities, and fat saturation should not affect R 2w *. Figure 7 shows example R 2w * maps for the phantoms. The exclusion technique without fat saturation removes all voxels with fat content > 15%. While this is valid for the NC tubes, it is inaccurate for those tubes with mixed voxels, since the R 2w * values used to assess cell density are not computed. The use of fat saturation appears to further reduce accuracy due to incomplete removal of fat signal. The dual-decay technique results in more stable R 2w * estimates for the mixed tubes and predicts lower R 2w * values for the NC controls, although ideally these two tubes would have even lower estimates.
The findings for the fat/water/cell mixture phantoms are summarized in Fig. 8 , where the R 2w * estimates are plotted against the known fat fractions to test the metric's invariance to fat content. Here, we show parameters estimated using a common-decay (where R 2w * = R 2f *) model alongside the dual-decay and exclusion techniques. The dual-decay gives the most stable R 2w * estimates across most fat fractions, while the reliability of the exclusion method deteriorates for fat ≥ 15%, and the estimated R 2 * from the common-decay model decreases with increased fat content. We note that acquiring data with a fat saturation pulse results in slight R 2w * underestimates from the dual-decay model, and wildly inconsistent R 2w * estimates from the exclusion technique.
In vivo
Finally, the dual-decay model was compared to singledecay and exclusion techniques in five mice in a C3 cervical cancer model, where SPIO-labeled CD8 + T cells were injected 24 h prior to imaging (20 days after cancer implant). Representative maps are shown for three mice in Fig. 9 . The proposed dual-decay technique exhibits fewer erroneously fit voxels than the single-decay model, and more voxels have non-zero R 2 * than with the exclusion method. However, the strict conditions imposed by the exclusion technique results in drastic underestimates for potentially mixed voxels (as illustrated in the in vitro data). Consequently, in mice 1 and 2 (and to a lesser extent mouse 3), no R 2w * values above threshold are seen in the tumor or adjacent lymph node, which is not consistent with the known behavior of these loaded cells.
We also show sample fits for several representative voxels in Fig. 9 . Voxel X is a voxel on the periphery of the tumor with no fat present, resulting in clean fits for both the single-decay and dual-decay methods, and with fat exclusion measuring the same R 2 * as single decay. However, voxel Y is in the lymph node and contains fat. This results in that voxel being excluded by the exclusion method and its relaxation rate is significantly overestimated (R 2 * > 800 s −1 ) by the single-decay method. The dual-decay method is able to fit the time course and return a reasonable value. Voxel Z is on the periphery of the tumor and also contains fat, resulting in R 2 * = 0 s −1 for the exclusion method. However, the presence of fat leads to divergent R 2 * values for single and dual decay. Values were estimated using (1) the elimination method, (2) a common-decay rate model (R 2w * = R 2f *), and (3) the proposed dual-decay model. Data were acquired with and without a fat saturation pulse. The dual-decay estimates are stable over the widest range of fat content and are least affected by fat saturation. Applied to data without fat saturation (FS), the common-decay method results in R 2 * estimates that decrease with fat content, as predicted
Discussion
The proposed comprehensive dual-decay Dixon model successfully provides accurate estimates of T 2w * despite changing fat content in simulated TurboSPI data. Simultaneously estimating these parameters improves accuracy in both fat fraction and T 2 * measurements, though only the T 2w * measurement is the focus of this work. We investigated T 2w * stability with respect to fat content for different levels of physical complexity: data that neglected T 2f *, data with a common T 2 *, and finally for the most physically descriptive case of independent T 2w * and T 2f *. The T 2w * values estimated using Fig. 9 Representative in vivo R 2 * maps from three mice bearing subcutaneous tumors. R 2 * maps were overlaid on anatomical bSSFP image and masked to tumor and nearby lymph nodes. Maps were produced by single-decay, exclusion, or the proposed dual-decay fitting techniques. Three voxels demonstrating unique fitting scenarios are also shown. Voxels X and Z are located on the tumor periphery, with voxel Y located inside of the tumor-draining inguinal lymph node.
For voxel X, single-decay and dual-decay have matched R 2 * values. In the lymph node voxel Y, dual decay is much better at fitting a time course containing fat and still calculating a reasonable R 2 * for ironlabeled cells, while single decay drastically overestimates R 2 * and fat exclusion sets it to zero. In voxel Z, both methods provide reasonable (though different) results; it is not clear which is correct based on the data available the dual-decay model compared favorably to gold standards obtained from using a simple mono-exponential fit on a simulated time course with no added fat. The in silico results suggest that the proposed model should give T 2w * estimates that are invariant to voxel fat content and thus result in more accurate and descriptive R 2 * maps.
A limitation of the in silico work was that it neglects the effects of unintended (i.e., not from SPIO) B 0 inhomogeneity to investigate the fit response. However, in translating the model to non-idealized data, we allowed Δω wf Δt and θ τ Δt to vary to reflect the time-dependent B 0 phase effect (ϕ = γΔB 0 Δt). This should be sufficient for the current investigation, since the goal is not to explicitly decouple or map these parameters, but to consider their combined effect.
Reeder and Horng [26, 28] acknowledge that a dual-decay model provides a more accurate description of the physical system, but is hindered by poor noise performance from adding more fit parameters. When using a common T 2 *, as suggested originally by Glover [35] , if T 2f * ≠ T 2w *, the common T 2 * will be an average that changes with fat content, which is detrimental to quantification of T 2 *. We tested this in Fig. 8 , but found that, in the in vitro and in silico experiments, using the more physically descriptive "dual" T 2 * model [25, 26] gave more accurate results, even though it added another parameter. Naturally, increasing the number of unknowns necessitates an increase in the number of measurements, but TurboSPI data (simulated or otherwise) are well equipped to provide this since ~ 200 points are routinely used in the fitting region for real data. A noise performance analysis using simulated Gaussian noise indicates that fit results stabilize at tSNR = 20 for both common and separate T 2 *.
When applied to in vitro data, as predicted, the dualdecay signal model provided R 2w * estimates that were more resistant to changes due to high fat content in mixed voxels, as compared to the exclusion technique or common-decay model. The benefits of using a more comprehensive model becomes apparent when fat content rises above ≥ 15%; all techniques were similarly stable in their estimates for fat < 15%, but the standard deviation of the exclusion technique increased at 15%, and accuracy deteriorated further for higher fat contents. The large standard deviations exist because these samples are at the threshold of exclusion, When using a common-decay rate to fit data acquired without fat saturation, we note that the R 2 * estimates decrease linearly with increased fat content (dark green points on Fig. 8) , reflecting a mixing of the two different relaxation rates.
Fat saturation had a significant impact on R 2w * estimates when using both the exclusion and common-decay techniques. Without fat saturation, mixed voxels with fat content > 15% were removed from the map calculated using the exclusion technique, meaning that any SPIO-labeled cells present will be ignored. After fat saturation, the exclusion method gave overestimates of R 2w * for 20% and 30% fat and eliminated mixed voxels with fat content of 40%. When fat is present in small quantities, the fat saturation pulse suppresses enough of the fat signal to evade exclusion, but the remaining fat signal still influences the overall amplitude near the spin echo, resulting in overestimated R 2w *. At larger fat contents, fat saturation is less effective; thus, more fat signal remains, the periodicity of the signal is maintained, and these voxels are detected and removed by the exclusion method.
The common-decay estimates were also affected by fat saturation when fat is present in small quantities. Again, the fat remaining after incomplete suppression results in a distorted time course, causing unstable fits. The dual-decay model was better able to parse this distorted signal. R 2w * estimate should ideally be invariant to a voxel's fat content and to fat saturation, and these in vitro data demonstrate the improved accuracy of the proposed dual-decay technique. In addition to being more invariant to fat content, the R 2w * measurements from dual decay were also less affected by the fat saturation pulse. However, while the effect was not as severe, fat saturation did consistently result in slight underestimates of R 2w * by the dual-decay method. These underestimates were likely due to SPIO-induced line broadening in the sample and partial saturation of the water peak, even when using a spectrally selective fat saturation pulse.
In vitro findings suggest that the dual-decay model should result in fewer misfit voxels, improving in vivo specificity while maintaining sensitivity to mixed voxels. Other techniques could assist in further discriminating SPIO-labeled cells from pure fat; for example, future implementations may consider an adaptive approach that uses fat content to prescribe the fitting technique on a voxel-by-voxel basis. That is, the dual-decay model could be used as a first-pass fitting method, with the single-decay model re-applied to voxels below a certain fat threshold, and with voxels above a certain fat threshold eliminated. This adaptive approach would provide the benefits of each technique.
One alternative to negative-contrast techniques such as TurboSPI is SWIFT, which provides positive contrast in regions of high magnetic susceptibility. SWIFT has been used for detection of labeled stem cells [36] and quantification of iron particles in suspension [37] , though there are no reports to date of quantification of labeled cells, which represents an area for possible exploration. However, since fat represents an additional source of off-resonance signal, its presence may mimic the positive contrast from iron and would have to be accounted for, using approaches similar to that described in this work but adapted for intensity-based quantification.
The present work uses a simplified lipid spectral model. Comprehensive spectral modeling is less crucial to this work than in applications that require more accurate fat quantification. The reasoning is similar to those fat-focused publications which note that while using separate R 2w * and R 2f * values is more physically accurate, the benefit is not worth the additional model parameter. Since this work focuses on accurate R 2 * quantification, multi-peak fat spectra may not be beneficial enough to be worth complicating the model. Nonetheless, it is a potential avenue for future work. As well, with data of sufficient quality it may be feasible to model the entire rise and fall of the spin echo including the non-linear exponential behavior around the peak, which has been shown theoretically [27, 32] and experimentally [38] . This might allow further enhancements to quantification of systems containing labeled cells.
Despite the limitations noted above, the proposed technique performed well on in vivo data. Figure 9 shows in vivo R 2w * as calculated by three fitting techniques (single decay, exclusion, dual decay) for three mice. R 2w * data are masked to the tumor and surrounding tissues, including the fat pad inferior to the tumor. The single-decay map clearly overestimates R 2w *, and thus cell density, in the tumor. While the exclusion technique exhibits the fewest erroneously fit fat voxels, it simply fits far fewer voxels overall. The in vitro data demonstrated that this exclusion technique is not sensitive to voxels with mixed content. Therefore, this map certainly excludes some voxels containing SPIO-labeled cells and would underestimate cell density. In the tumor, the bSSFP image shows a hypointense region that is not shown to have high R 2w * by any mapping technique-this is likely necrosis. However, there are hypointense regions which have high R 2w * on the single-decay and the dual-decay maps but are nearly ignored by the exclusion technique. The proposed dual-decay technique is less sensitive to misidentification of fat voxels than the single-decay fit while retaining mixed voxels of fat and iron unlike single-decay with post-hoc exclusion. It should be noted that there are still voxels (such as voxel Z, shown in Fig. 9 ) in which it is not clear if the dual decay is fitting as expected, since that particular voxel appears to be slightly misfit, resulting in a slight overestimation of R 2 *. Future work in multi-spectral fat evaluation may improve the performance of the proposed method in such cases.
Unfortunately, it is difficult to validate these experiments in vivo, due to the limitations involved in quantifying cells using confocal microscopy or flow cytometry while successfully co-localizing these methods with the 3D MRI ROI. It is also challenging to quantify fat concentration using histology on a voxel level, as traditional techniques often require ROIs of several millimeters in size. While validation may not necessarily be possible in vivo, we evaluate potential phantom setups containing cells with fat in a more biologically relevant matrix that could be digested after imaging for validation. Other MRI-based spatially resolved fat measurement techniques under development [39] may serve in this role as at least an independent estimation of fat content, if not a true gold standard. Regardless, we believe that this work offers valuable preliminary insights into improving quantification of SPIOlabeled cells in biological regions with varying amounts of fat.
Conclusion
The principal objective of this work was to investigate the adverse effect of contaminant fat modulations in TurboSPI and propose corrective methods. R 2 * estimates should be invariant to fat content, but single-species mono-exponential R 2 * mapping fails in the presence of fat. This is detrimental to in vivo cell tracking studies that measure cell density via R 2 * mapping, since mixed-content voxels arise in tumors and lymph nodes surrounded by adipose tissue. In silico data show that R 2 * estimates are stable across most fat fractions if R 2w *, R 2f * and fat fraction are estimated simultaneously using a modified dual-decay Dixon model. This finding was corroborated by an in vitro experiment in which the proposed model outperformed previous methods when SPIO-labeled cells are present with fat ≥ 15%. Preliminary in vivo results indicate positive development with an improved balance of detecting voxels that have a mix of iron and fat while still returning reasonable R 2 * values. Therefore, the proposed model is a promising tool for quantitative TurboSPI R 2 * cell tracking, with further refinements offering the possibility of better specificity and sensitivity.
